BDSX Q3 2025 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena

BDSXBiodesix, Inc.

$151M

Q3 2025 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$22M+19.9% YoY

Gross Profit

$18M81.1% margin

Operating Income

-$7M-32.4% margin

Net Income

-$9M-40.0% margin

EPS (Diluted)

$-1.16

QoQ Revenue Growth

+8.7%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$89M

Total Liabilities

$90M

Stockholders' Equity

-$2M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$22M	$18M	+19.9%
Gross Profit	$18M	$14M	+26.4%
Operating Income	-$7M	-$9M	+17.9%
Net Income	-$9M	-$10M	+15.0%

Revenue Segments

Diagnostic Tests

$20M91%

Development Services

$2M9%